Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Insulin signaling pathways in chronic diseases
Details
Insulin is an important physiological anabolic agent known, for enhancing the synthesis and storage of lipids, carbohydrates, and protein, and preventing their breakdown and liberation into circulation. It plays an important role in cell nutrient uptake, usage, and storage. Insulin resistance is the main characteristic of type 2 diabetes; it is a condition where cells fail to adequately respond to insulin. It is caused by different alterations, including a decrease in the number of insulin receptors and their catalytic activity, increased Ser/Thr phosphorylation, an increase in Tyr phosphatase activity, mainly PTP-1B, which causes receptor and IRS dephosphorylation, a decrease in PI3K and Akt kinases activity, and defects in GLUT-4 expression and function.
Autorentext
Mona Anwar Mohamed El-Bana, a professor at the National Research Centre, advances medical biochemistry through research and teaching. Her work focuses on disease mechanisms, metabolic disorders, and neurodegeneration. She mentors students, contributes to scientific knowledge, and bridges research with clinical applications for improved healthcare.
Weitere Informationen
- Allgemeine Informationen
- Sprache Englisch
- Herausgeber Scholars' Press
- Gewicht 96g
- Untertitel How the defect in Insulin signaling pathways involves the chronic diseases
- Autor Mona El-Banna , Dalia Medhat
- Titel Insulin signaling pathways in chronic diseases
- Veröffentlichung 10.10.2022
- ISBN 6138973356
- Format Kartonierter Einband
- EAN 9786138973355
- Jahr 2022
- Größe H220mm x B150mm x T4mm
- Anzahl Seiten 52
- GTIN 09786138973355